The total return over the past 12 months is +150.87% vs. +16.94% for the S&P 500. So far it's up +113.64% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +150.87% | +94.28% | (5.50%) | N/A | N/A | N/A |
| Total Return CAGR | +150.87% | +94.28% | (5.50%) | N/A | N/A | N/A |
| Revenue CAGR | (60.77%) | (20.52%) | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Dianthus Therapeutics, Inc. (DNTH)
| Year | Start price | End price | DNTH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $41.21 | $88.04 | +113.64% | +14.51% | +99.13% |
| 2025 | $21.80 | $41.21 | +89.04% | +17.72% | +71.32% |
| 2024 | $10.40 | $21.80 | +109.62% | +24.89% | +84.73% |
| 2023 | $6.32 | $10.40 | +64.56% | +26.19% | +38.37% |
| 2022 | $70.88 | $6.32 | (91.08%) | (18.17%) | (72.91%) |
| 2021 | $125.44 | $70.88 | (43.49%) | +28.74% | (72.23%) |
| 2020 | $242.56 | $125.44 | (48.28%) | +18.37% | (66.65%) |
| 2019 | $91.20 | $242.56 | +165.96% | +31.22% | +134.74% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
